BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 12627039)

  • 1. Raloxifene is a better antioxidant of low-density lipoprotein than estradiol or tamoxifen in postmenopausal women in vitro.
    Arteaga E; Villaseca P; Bianchi M; Rojas A; Marshall G
    Menopause; 2003; 10(2):142-6. PubMed ID: 12627039
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Raloxifene and Tamoxifen Reduce PARP Activity, Cytokine and Oxidative Stress Levels in the Brain and Blood of Ovariectomized Rats.
    Yazğan B; Yazğan Y; Övey İS; Nazıroğlu M
    J Mol Neurosci; 2016 Oct; 60(2):214-22. PubMed ID: 27372663
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of 17beta-estradiol and alpha-tocopherol on the oxidation of LDL cholesterol from postmenopausal women and the minor effect of gamma-tocopherol and melatonin.
    Arteaga E; Rojas A; Villaseca P; Bianchi M
    Menopause; 2000; 7(2):112-6. PubMed ID: 10746893
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phytoestrogens possess a weak antioxidant activity on low density lipoprotein in contrast to the flavonoid quercetin in vitro in postmenopausal women.
    Arteaga E; Villaseca P; Rojas A; Marshall G; Bianchi M
    Climacteric; 2004 Dec; 7(4):397-403. PubMed ID: 15799611
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ovariectomy-Induced Mitochondrial Oxidative Stress, Apoptosis, and Calcium Ion Influx Through TRPA1, TRPM2, and TRPV1 Are Prevented by 17β-Estradiol, Tamoxifen, and Raloxifene in the Hippocampus and Dorsal Root Ganglion of Rats.
    Yazğan Y; Nazıroğlu M
    Mol Neurobiol; 2017 Dec; 54(10):7620-7638. PubMed ID: 27832523
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro effect of estradiol, progesterone, testosterone, and of combined estradiol/progestins on low density lipoprotein (LDL) oxidation in postmenopausal women.
    Arteaga E; Rojas A; Villaseca P; Bianchi M; Arteaga A; Durán D
    Menopause; 1998; 5(1):16-23. PubMed ID: 9689190
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Comparison of the antioxidant effect of estriol and estradiol on low density lipoproteins in post-menopausal women].
    Arteaga E; Villaseca P; Rojas A; Arteaga A; Bianchi M
    Rev Med Chil; 1998 May; 126(5):481-7. PubMed ID: 9731428
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective estrogen receptor modulation prevents scoliotic curve progression: radiologic and histomorphometric study on a bipedal C57Bl6 mice model.
    Demirkiran G; Dede O; Yalcin N; Akel I; Marcucio R; Acaroglu E
    Eur Spine J; 2014 Feb; 23(2):455-62. PubMed ID: 24136418
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Different effects of raloxifene and estrogen on interleukin-1beta and interleukin-1 receptor antagonist production using in vitro and ex vivo studies.
    Rogers A; Clowes JA; Pereda CA; Eastell R
    Bone; 2007 Jan; 40(1):105-10. PubMed ID: 16934544
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of raloxifene and hormone replacement therapy on markers of serum atherogenicity in healthy postmenopausal women.
    Anderson PW; Cox DA; Sashegyi A; Paul S; Silfen SL; Walsh BW
    Maturitas; 2001 Jul; 39(1):71-7. PubMed ID: 11451623
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of raloxifene on the incidence of elevated low density lipoprotein (LDL) and achievement of LDL target goals in postmenopausal women.
    Cox DA; Sarkar S; Harper K; Barrett-Connor E
    Curr Med Res Opin; 2004 Jul; 20(7):1049-55. PubMed ID: 15265250
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential effects of raloxifene and continuous combined hormone replacement therapy on biochemical markers of cardiovascular risk: results from the Euralox 1 study.
    Nickelsen T; Creatsas G; Rechberger T; Depypere H; Erenus M; Quail D; Arndt T; Bonnar J;
    Climacteric; 2001 Dec; 4(4):320-31. PubMed ID: 11770189
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of alone and combination tamoxifen, raloxifene and estrogen on lipid profile and atherogenic index of ovariectomized type 2 diabetic rats.
    Ebrahimi MN; Khaksari M; Sepehri G; Karam GA; Raji-Amirhasani A; Azizian H
    Life Sci; 2020 Dec; 263():118573. PubMed ID: 33058909
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of estrogen target genes and growth by selective estrogen-receptor modulators in endometrial cancer cells.
    Dardes RC; Schafer JM; Pearce ST; Osipo C; Chen B; Jordan VC
    Gynecol Oncol; 2002 Jun; 85(3):498-506. PubMed ID: 12051881
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Randomized control study of the effects of raloxifene on serum lipids and homocysteine in older women.
    De Leo V; la Marca A; Morgante G; Lanzetta D; Setacci C; Petraglia F
    Am J Obstet Gynecol; 2001 Feb; 184(3):350-3. PubMed ID: 11228485
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the antioxidant effects of equine estrogens, red wine components, vitamin E, and probucol on low-density lipoprotein oxidation in postmenopausal women.
    Bhavnani BR; Cecutti A; Gerulath A; Woolever AC; Berco M
    Menopause; 2001; 8(6):408-19. PubMed ID: 11723413
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A randomised clinical trial to study the effects of raloxifene hydrochloride on bone mineral density, biochemical markers of bone metabolism and serum lipids in postmenopausal women].
    Zheng SR; Wu YY; Zhang ZL; Yang X; Hui Y; Zhang Y; Chen SL; Den WH; Liu H; Ekangaki A; Stocks J; Harper K; Liu JL
    Zhonghua Fu Chan Ke Za Zhi; 2003 Apr; 38(4):226-9. PubMed ID: 12885371
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of postmenopausal women with osteoporosis or low bone density with raloxifene. Raloxifene Study Group.
    Meunier PJ; Vignot E; Garnero P; Confavreux E; Paris E; Liu-Leage S; Sarkar S; Liu T; Wong M; Draper MW
    Osteoporos Int; 1999; 10(4):330-6. PubMed ID: 10692984
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparing the effects of 17β-oestradiol and the selective oestrogen receptor modulators, raloxifene and tamoxifen, on prepulse inhibition in female rats.
    Gogos A; van den Buuse M
    Schizophr Res; 2015 Nov; 168(3):634-9. PubMed ID: 25979306
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transition to raloxifene with and without low-dose estrogen therapy in postmenopausal women: effects on serum lipids and fibrinogen - a pilot study.
    O'Neill SM; Eden J; Baber R; Ekangaki A; Stocks JM; Wolthers T; Davis SR
    Climacteric; 2003 Dec; 6(4):347-53. PubMed ID: 15006256
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.